Article
SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Oct 2015
Zhang Xiaotun, Coleman Ilsa M, Brown Lisha G, True Lawrence D, Kollath Lori, Lucas Jared M, Lam Hung-Ming, Dumpit Ruth, Corey Eva, Chéry Lisly, Lakely Bryce, Higano Celestia S, Montgomery Bruce, Roudier Martine, Lange Paul H, Nelson Peter S, Vessella Robert L, Morrissey Colm
Abstract excerpt
PURPOSE: The neuroendocrine phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the neuroendocrine phenotype in CRPC. EXPERIMENTAL DESIGN: Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and prostate-specific antigen (PSA) was analyzed by IHC in 155 CRPC metastases from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
